Resveratrol attenuates early diabetic nephropathy by down-regulating glutathione S-transferases Mu in diabetic rats

Journal of Medicinal Food

Volumn 16, Issue 6, 2013, Pages 481-486

  Jiang, Bei ^a   Guo, Ling ^a   Li, Bao Ying ^a   Zhen, Jun Hui ^a   Song, Jian ^a   Peng, Tao ^a   Yang, Xiang Dong ^a   Hu, Zhao ^a   Gao, Hai Qing ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Diabetic nephropathy; Glutathione S transferases Mu; Mesangial cells; Resveratrol

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CREATININE; GLUCOSE; GLUTATHIONE S TRANSFERASE MU; GLUTATHIONE TRANSFERASE; RESVERATROL; STREPTOZOCIN; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CELL CULTURE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DRUG EFFECT; DRUG MECHANISM; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; HISTOLOGY; IN VITRO STUDY; KIDNEY HYPERTROPHY; KIDNEY MASS; MALE; MESANGIUM CELL; NONHUMAN; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RAT; RENAL PROTECTION; WESTERN BLOTTING;

ANIMALS; DIABETIC NEPHROPATHIES; DOWN-REGULATION; GLUCOSE; GLUTATHIONE TRANSFERASE; HUMANS; KIDNEY; MALE; MESANGIAL CELLS; NF-E2-RELATED FACTOR 2; RATS; RATS, WISTAR; STILBENES;

RATTUS; RATTUS NORVEGICUS;

EID: 84879347775     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2012.2686     Document Type: Article

References (25)

1. Atkins RC, Zimmet P: Diabetic kidney disease: Act now or pay later. Nephrol Dial Transplant 2010;25:331-333
2. Zheng F, Guan Y: Thiazolidinediones: A novel class of drugs for the prevention of diabetic nephropathy? Kidney Int 2007;72:1301- 1303
3. Debnam ES, Unwin RJ: Hyperglycemia and intestinal and renal glucose transport: Implications for diabetic renal injury. Kidney Int 1996;50:1101-1109
4. Choudhury D, Tuncel M, Levi M: Diabetic nephropathy - a multifaceted target of new therapies. Discov Med 2010;10:406- 415
5. Szkudelski T: Resveratrol-induced inhibition of insulin secretion from rat pancreatic islets: Evidence for pivotal role of metabolic disturbances. Am J Physiol Endocrinol Metab 2007;293:E901- E907
6. El-Mowafy AM, Alkhalaf M: Resveratrol activates adenylylcyclase in human breast cancer cells: A novel, estrogen receptorindependent cytostatic mechanism. Carcinogenesis 2003;24: 869-873
7. Miller NJ, Rice-Evans CA: Antioxidant activity of resveratrol in red wine. Clin Chem 1995;41:1789
8. Das S, Alagappan VK, Bagchi D, et al.: Coordinated induction of iNOS-VEGF-KDR-eNOS after resveratrol consumption: A potential mechanism for resveratrol preconditioning of the heart. Vasc Pharmacol 2005;42:281-289
9. Hung LM, Chen JK, Huang SS, et al.: Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovasc Res 2000;47:549-555
10. Harikumar KB, Aggarwal BB: Resveratrol: A multitargeted agent for age-associated chronic diseases. Cell Cycle 2008;7:1020- 1035
11. Su HC, Hung LM, Chen JK: Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. Am J Physiol Endocrinol Metab 2006;290:E1339-E1346
12. Zang M, Xu S, Maitland-Toolan KA, et al.: Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 2006;55:2180-2191
13. Chen KH, Hung CC, Hsu HH, et al.: Resveratrol ameliorates early diabetic nephropathy associated with suppression of augmented TGF-b/Smad and ERK1/2 signaling in streptozotocininduced diabetic rats. Chem Biol Interact 2011;15:45-53
14. Ding DF, You N, Wu XM, et al.: Resveratrol attenuates renal hypertrophy in early-stage diabetes by activating AMPK. Am J Nephrol 2010;31:363-374
15. Kitada M, Kume S, Imaizumi N, et al.: Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/ SIRT1-independent pathway. Diabetes 2011;60:634-643
16. Lee MJ, Feliers D, Sataranatarajan K, et al.: Resveratrol ameliorates high glucose-induced protein synthesis in glomerular epithelial cells. Cell Signal 2010;22:65-70
17. Li BY, Cheng M, Gao HQ, et al.: Back-regulation of six oxidative stress proteins with grape seed proanthocyanidin extracts in rat diabetic nephropathy. J Cell Biochem 2008;104:668-679
18. Fujita H, Haseyama T, Kayo T, et al.: Increased expression of glutathione S-transferase in renal proximal tubules in the early stages of diabetes: A study of type-2 diabetes in the Akita mouse model. Exp Nephrol 2001;9:380-386
19. Bekris LM, Shephard C, Peterson M, et al.: Glutathiones- transferase M1 and T1 polymorphisms and associations with type 1 diabetes age-at-onset. Autoimmunity 2005;38:567-575
20. Alsaad KO, Herzenberg AM: Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: An update. J Clin Pathol 2007;60:18-26
21. Chen S, Jim B, Ziyadeh FN: Diabetic nephropathy and transforming growth factor-beta: Transforming our view of glomerulosclerosis and fibrosis build-up. Semin Nephrol 2003;23:532-543
22. Young BA, Johnson RJ, Alpers CE, et al.: Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int 1995;47:935-944
23. Awazu M, Ishikura K, Hida M, et al.: Mechanisms of mitogenactivated protein kinase activation in experimental diabetes. J Am Soc Nephrol 1999;10:738-745
24. Ichijo H, Nishida E, Irie K, et al.: Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 1997;275:90-94
25. Cho SG, Lee YH, Park HS, et al.: Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1. J Biol Chem 2001;276:12749-12755